Sitka Eguiluz-Hernandez

2018 journal article

The anti-inflammatory effect of topical tofacitinib on immediate and late-phase cutaneous allergic reactions in dogs: a placebo-controlled pilot study

VETERINARY DERMATOLOGY, 29(3), 250-+.

By: A. Blubaugh*, D. Rissi*, D. Elder*, T. Denley*, S. Eguiluz-Hernandez n & F. Banovic*

MeSH headings : Animals; Anti-Inflammatory Agents / therapeutic use; Dermatitis, Atopic / drug therapy; Dermatitis, Atopic / veterinary; Dog Diseases / drug therapy; Dogs; Hypersensitivity, Delayed / drug therapy; Hypersensitivity, Delayed / veterinary; Hypersensitivity, Immediate / drug therapy; Hypersensitivity, Immediate / veterinary; Inflammation / drug therapy; Inflammation / veterinary; Pilot Projects; Piperidines / pharmacology; Pyrimidines / pharmacology; Pyrroles / pharmacology
TL;DR: It is suggested that topical tofacitinib exerts an inhibitory effect on activated canine skin-emigrating immune cells; this drug should be investigated further as a topical immunosuppressive drug in dogs. (via Semantic Scholar)
UN Sustainable Development Goal Categories
3. Good Health and Well-being (Web of Science; OpenAlex)
Source: Web Of Science
Added: August 6, 2018

Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.

Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.